IL-22对角质形成细胞表达HB-EGF及TIG3作用机制的研究
[Abstract]:Psoriasis is a common chronic recurrence of erythema and scaly disease. This disease can be divided into 4 types: common type, arthropathy, erythroderma type and pustular type. The pathogenesis is chronic and recurrent. The pathogenesis of this disease is not completely clear. At present, the pathogenesis of psoriasis is mainly attributed to auxiliary Th cells and related cell causes. An inflammatory response.Th22 cell targeting keratinocyte as a target is a newly discovered CD4+ auxiliary T cell subgroup, highly expressed in the peripheral blood of psoriasis, and its main cytokine is IL-22. through which the related biological functions are realized. In the peripheral blood and skin lesions of psoriasis patients, the IL-22 level and the severity of psoriasis are obvious. Our previous study shows that heparin binding to epidermal growth factor like growth factor (heparin-binding epidermal-growth-factor-like growth factor, HB-EGF) plays an important role in the abnormal proliferation and prognosis of epidermal KC in psoriasis. Previous studies in this study show that IL-22 can induce Ha Ca T cell expression in vitro. EGF, but the mechanism of action is not clear, the mitogen activated protein kinase (MAPK-ERK1/2) pathway and the transcription activating factor pathway (JAK/STAT) are the two signaling pathways that play an indispensable role in the pathogenesis of psoriasis. The gene 3 (Tazarotene-induced gene 3, TIG3) is a tumor suppressor,.TIG3, which regulates the keratinocyte The proliferation and differentiation of psoriasis and the decrease of expression in psoriasis. In summary, we speculate that IL-22 promoting KC secretion may be related to the two signaling pathways of MAPK-ERK1/2 and JAK/STAT, and that there is a certain relationship between TIG3 expression and.IL-22 by promoting HB-EGF expression and inhibiting the TIG3 expression to participate in the occurrence and development of silver chip disease. This experiment studies IL-22 promoting HaCaT thin. The mechanism of cell secretion of HB-EGF and its effect on the secretion of TIG3 by HaCaT cells. Objective: To study the mechanism of the action of interleukin 22 (Interleukin-22, IL-22) on the expression of HB-EGF in keratinocytes and the mechanism of its effect on the expression of TIG3. Methods: 1, IL-22 and 24 hours are used at different concentrations (12.5 mu g/L, 25 u g/L, 50 mu g/L, 100 mu g/L). After that, the total protein of cell was extracted and the effects of IL-22 on the two signal pathways of MAPK-ERK1/2 and JAK/STAT were detected by Western blot, and the total protein and total m were extracted after the action of PD98059 and AG490 and IL-22 on Ha Ca T cells. The effect of transcriptional polymerase chain reaction (RT-PCR) on the secretion of HB-EGF in Ha Ca T cells was detected. SPSS 17 statistical software was used for statistical processing. P0.05 found a significant difference in.2. Imiquimod induced psoriasis like skin lesions in the skin of mice on the back, and then subcutaneous injection of 1 UU IL-22,48h to kill the mice and take the lower back. Skin, HE staining was used to observe the changes in the skin of mice. The expression of HB-EGF was observed by immunohistochemical staining,.3, with the different concentrations (12.5 g/L, 25 g/L, 50, g/L, 100 g/L) IL-22 and the application related signaling pathway blockers, PD98059 and AG490 and IL-22. Location, the total protein and total m RNA were extracted, and the effect of Western blot, ELISA and real-time fluorescent quantitative RT-PCR on the secretion of TIG3 was detected by Ha Ca T cell. The SPSS 17 statistical package was used for statistical processing. The increase of K1/2 protein and the increase of P-JAK2 and P-STAT3 protein in the JAK2/STAT3 signaling pathway. The expression of HB-EGF protein and m RNA after adding signal pathway specific inhibitor PD98059 and AG4 90 is significantly lower than that in IL-22 intervention group. Imiquimod continues to act on the back of Bal mice, and can induce psoriasis like skin lesions in mice. The expression of HB-EGF in the skin epidermis of normal Bal B/c mice and psoriasis mice increased by.3. IL-22 could cause the decrease of TIG3 protein level in Ha Ca T cells. The intensity and concentration of its action were related to the concentration of TIG3 in the cells of different concentrations of IL-22 treatment group than that of the control group. The inhibitory effect of expression was gradually enhanced. The inhibitory effect of PD98059 and IL-22 on TIG3 decreased compared with the IL-22 group. The difference was statistically significant. Conclusion: IL-22 can cause MAPK-ERK1/2 and JAK2/STAT3 in Ha Ca T cells to induce two signaling pathways to induce the effect of.IL-22 cells. The mechanism may be related to the two signaling pathways of MAPK-ERK1/2 and JAK2/STAT3 that.IL-22 can cause the HB-EGF expression in the normal skin of Bal B/c mice and the HB-EGF expression in the epidermis of psoriasis like skin lesions. The.IL-22 can inhibit TIG3 expression in Ha Ca T cells. The inhibitory effect is related to the IL-22 concentration. The mechanism of action may be associated with the letter and the letter The number path is related.
【学位授予单位】:天津医科大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R758.63
【相似文献】
相关期刊论文 前10条
1 吴京海,金岚,吴惠t ,秦立模,朱丽芬,吴文媛,秦万章;可溶性细胞粘附分子表达与银屑病疾病活动的相关性[J];中国皮肤性病学杂志;2000年04期
2 张晓红,瞿幸,周志强,牛福林,张建中;消银解毒饮对银屑病患者鳞屑白介素8的影响[J];中华皮肤科杂志;2000年02期
3 刘涛峰,张学军,杨森,王福喜,魏生才,陈珊宇;银屑病诱发因素的病例对照研究[J];中华皮肤科杂志;2000年05期
4 张力军,杨雪琴,樊建勇,刘秀清;银屑病患者血浆血管紧张素Ⅱ水平检测[J];中华皮肤科杂志;2000年06期
5 冯素英,靳培英;饮酒和银屑病[J];国外医学.皮肤性病学分册;2000年04期
6 孙军红,方跃明,郑茂荣;银屑病与中性粒细胞趋化因子[J];国外医学.皮肤性病学分册;2000年05期
7 李占国,秦社玲,张素红,张长军;整体综合思维在银屑病诊治中的应用[J];皮肤病与性病;2000年02期
8 曹序浦;老药新用治疗银屑病[J];天津药学;2000年03期
9 陈英,智强,朱年春;重组人白细胞介素-10对银屑病患者外周血单个核细胞的作用[J];中国临床药理学与治疗学;2000年04期
10 霍秀琪;银屑病治疗的进展[J];医学文选;2000年05期
相关会议论文 前10条
1 范斌;李斌;;银屑病与肥胖新进展[A];2009全国中西医结合皮肤性病学术会议论文汇编[C];2009年
2 范平;张禁;黎超;;127例长期缓解的银屑病共同点调查分析[A];2009全国中西医结合皮肤性病学术会议论文汇编[C];2009年
3 郑厚峰;;根据三个基因分类的银屑病临床特征比较[A];中华医学会第十五次全国皮肤性病学术会议论文集[C];2009年
4 涂彩霞;齐晓怡;;银屑病治疗的整体观——生活方式和饮食[A];2010全国中西医结合皮肤性病学术会议论文汇编[C];2010年
5 杨雪琴;;对银屑病30年的研究和认识[A];中华医学会第16次全国皮肤性病学术年会摘要集[C];2010年
6 付翔宇;陈宏;;银屑病的危险因素(摘要)[A];第五届全国中西医结合变态反应学术会议论文集[C];2011年
7 王刚;;特殊类型银屑病的治疗[A];2011全国中西医结合皮肤性病学术会议论文汇编[C];2011年
8 沙海松;;陈凯教授对银屑病的中西医治疗经验[A];中华中医药学会学术会议、国家中医药管理局继续教育项目——银屑病中医药防治交流会暨赵炳南学术思想高级研修班论文集[C];2011年
9 樊建勇;杨雪琴;张力军;刘秀清;;银屑病患者血中糖皮质激素及其受体mRNA的测定及其意义[A];2001年中国中西医结合皮肤性病学术会议论文汇编[C];2001年
10 潘德海;张晓艳;郑占财;刘永生;;染发剂过敏诱发银屑病8例[A];第一届全国变态反应学术研讨会论文汇编[C];2001年
相关重要报纸文章 前10条
1 蒲成学;烟酒与银屑病[N];中药报;2000年
2 牧童;银屑病怎样防[N];中国中医药报;2007年
3 记者严少卫;银屑病诊治应重视心理疏导[N];健康报;2009年
4 本报记者 海霞 吴大卫 夏厦;关爱银屑病患者[N];中国中医药报;2009年
5 郭艳丽;引起银屑病的4大因素[N];农村医药报(汉);2009年
6 本报记者 徐亚静;银屑病宁可不治莫乱治[N];中国医药报;2009年
7 山西省晋中市第三人民医院 张英栋;治银屑病当重疗心[N];中国中医药报;2010年
8 记者 顾泳;上海银屑病发病率约0.2%[N];解放日报;2010年
9 山西中医学院中西医结合医院 张英栋;从系统理论解读汗对银屑病防治的重要性[N];中国中医药报;2012年
10 记者 田雅婷;我国银屑病患者仅15%接受正规治疗[N];光明日报;2012年
相关博士学位论文 前10条
1 杨海平;银屑病激发因素的调查与防治对策的研究[D];中国协和医科大学;1999年
2 李龙年;汉族人群与欧美人群银屑病易感基因的遗传异质性研究[D];安徽医科大学;2015年
3 金海蓉;白藜芦醇脂质体凝胶对小鼠银屑病模型的治疗及经皮给药药代动力学研究[D];第二军医大学;2015年
4 徐丽敏;银屑病细胞因子异常表达及相关药物的研究[D];天津大学;2007年
5 陈静;银屑病患者皮损和外周血中浆细胞样树突状细胞,TLR9、IRF-7、IFN-αmRNA表达研究[D];华中科技大学;2008年
6 高春芳;转化生长因子βs及受体在银屑病皮损和外周血中的表达与意义[D];第二军医大学;2001年
7 唐玲;银屑病患者朗格汉斯细胞异常机制的研究[D];第二军医大学;2001年
8 李波;银屑病与肿瘤坏死因子基因多态性相关研究[D];中国医科大学;2002年
9 陈小红;β-溶血性链球菌、结核分支杆菌与银屑病相关性研究[D];中国协和医科大学;2002年
10 孙联文;抗银屑病相关药物及化合物对花生四烯酸系统中5-脂氧合酶代谢途径的影响[D];中国协和医科大学;2001年
相关硕士学位论文 前10条
1 李怀军;银屑病临床相关因素的回顾性分析[D];黑龙江中医药大学;2009年
2 罗庆;银屑病社会心理因素调查研究[D];湖北中医学院;2009年
3 吉莉;银屑病患者的疾病感知和应激、应对[D];华东师范大学;2009年
4 任为;IL23R基因多态性与汉族人银屑病易感性关联分析研究[D];安徽医科大学;2009年
5 田雅;527例银屑病住院患者临床分析[D];新疆医科大学;2009年
6 赵艳霞;银屑病的发病与治疗的回顾性分析[D];成都中医药大学;2003年
7 刘爱花;银屑病危险因素研究[D];天津医科大学;2007年
8 梁兴龙;62例银屑病住院患者回顾性临床分析[D];汕头大学;2011年
9 李俊丽;银屑病治疗现状及进展[D];重庆医科大学;2013年
10 吕艳;阿维A对银屑病患者血脂影响的回顾性分析[D];郑州大学;2015年
,本文编号:2128668
本文链接:https://www.wllwen.com/yixuelunwen/pifb/2128668.html